[生物医药论文精品a]肿瘤坏死因子相关凋亡诱导配体:皮肤病治疗新的药物作用靶点_第1页
[生物医药论文精品a]肿瘤坏死因子相关凋亡诱导配体:皮肤病治疗新的药物作用靶点_第2页
[生物医药论文精品a]肿瘤坏死因子相关凋亡诱导配体:皮肤病治疗新的药物作用靶点_第3页
[生物医药论文精品a]肿瘤坏死因子相关凋亡诱导配体:皮肤病治疗新的药物作用靶点_第4页
[生物医药论文精品a]肿瘤坏死因子相关凋亡诱导配体:皮肤病治疗新的药物作用靶点_第5页
已阅读5页,还剩1页未读 继续免费阅读

下载本文档

版权说明:本文档由用户提供并上传,收益归属内容提供方,若内容存在侵权,请进行举报或认领

文档简介

1肿瘤坏死因子相关凋亡诱导配体皮肤病治疗新的药物作用靶点A1A0A2A4A3A6A5A7A9A8A10A11A12A13A15A14A11A16A17A13A18A20A21A14200433【摘要】肿瘤坏死因子相关凋亡诱导配体(TRAIL)是肿瘤坏死因子超家族成员之一,具有选择性的诱导变异细胞的凋亡,对维持机体内环境的稳定具有重要作用,由于TRAIL具有调节皮肤的增生、凋亡、炎症、免疫、维持皮肤器官内环境的稳定等特点,在皮肤疾病研究中成为热点。本文将综述TRAIL在黑色素瘤、特应性皮炎、皮肤利什曼原虫病、银屑病关节炎等皮肤疾病中的研究进展,提示TRAIL可能作为某些皮肤疾病药物治疗的新靶点。【关键词】TRAIL;皮肤;皮肤疾病;凋亡DEVELOPMENTOFTRAILRESEARCHINSKINDISEASEYANGJISHUN,HUJINHONG,LIUJIYONG,ZHUQUANGANG,LIFENGQIANDEPARTMENTOFPHARMACY,CHANGHAIHOSPITAL,SECONDMILITARYMEDICALUNIVERSITY,SHANGHAI200433,CHINA【ABSTRACT】TUMORNECROSISFACTORTNFRELATEDAPOPTOSISINDUCINGLIGAND,TRAILISONEOFMEMBERSOFTHETNFGENESUPERFAMILYTHATINDUCESAPOPTOSISOFMANYTRANSFORMEDCELLSSELECTIVELYITISIMPORTANTTOSUSTAINSTABILITYOFINTERNALENVIRONMENTTRAILISABLETOREGULATEPROLIFERATION,APOPTOSIS,INFLAMMATION,IMMUNITYETALINSKIN,WHICHHASCOMPREHENSIVESTUDYINSKINDISEASETHISPAPERWILLREVIEWTRAILDEVELOPMENTINSKINDISEASEINCLUDINGMELANOMA,AD,CUTANEOUSLEISHMANIASIS,PSORIATICARTHRITISETALITINDICATESTHATTRAILMIGHTSERVEASANEWDRUGTARGETFORSKINDISEASE【KEYWORDS】TRAILSKINSKINDISEASEAPOPTOSIS肿瘤坏死因子相关凋亡诱导配体TUMORNECROSISFACTORTNFRELATEDAPOPTOSISINDUCINGLIGAND,TRAIL,是最近发现的TNF超家族新型凋亡分子,其胞外区与FASL具有较高的同源性,它能选择性的诱导肿瘤细胞、变异细胞以及病G8614G5875G7591的细胞发生凋亡,G13792对G8503G5132细胞G8821有G7186G14891G8614性,G5194G1000TRAIL在诱导细胞凋亡G17819G12255中,具有较TNF、FASLG6164G5353G17227的炎症G2465应G7138G7186较G4581的G1260G2195,在与增生、凋亡相关的疾病中G5483G2052G5203G8879的研究,本文对TRAIL在皮肤疾病研究中的进展进G15904综述。1TRAIL及其受体A19A22A23A24A25A26A27A28A291982A30A31A32A31A33A34A31A35A36A37A38A39A40A41EMAILJASUNYANGHOTMAILCOMA42A43A19A22A23A24A25A44A45A46A291949A30A31A47A31A33A34A31A48A49A31A50A51A52A53A31A37A38A54A55A25A56A57A52A58A59EMAILHUJHSMMUEDUCN2TRAILG2460G12228为APO2LG6122TNFSF10,G13546G11733G1147物G4658于II型G17340G14192G15519G11345,G5203G8879分G5079于G14098、G13966、G13970、G13940G17959、外G2620G15892细胞及G13986G11436等G8503G5132G13464G13467。TRAILG17902G17819与靶细胞G15932G19766的G2475体G13479G2524G13792发G6393生G10714作用。G11458G2081发现的G1166G12879G6164具有的特异性TRAILG14192G2475体有5G1022,G18129G4658于I型G17340G14192G15519G11345,分G2047为死亡G2475体TRAILR1/DR4、TRAILR2/DR5G2656诱G20587G2475体TRAILR3G715DCR1、TRAILR4G715DCR2及可G9354性OPGOSTEOPROTEGERIN,其中DR4、DR5的胞内区G2559有死亡G13479G7512G3507(DEATHDOMAIN,DD),G17902G17819诱导凋亡G1461G2507G17728导G5353发细胞凋亡。DCR1、DCR2的胞外区与DR4、DR5具有高G5242的同源G8700G3534G18252G5219G2027,G1306由于DCR1G13582G4581胞G17148内的死亡G2163能区,DCR2具有G993G4448G6984的死亡G13479G7512G3507,因G13792G1120G13785G993能G1268导细胞内的凋亡G1461G2507,G1306能与DR4、DR5G12466G1117性G13479G2524TRAIL因子,G1186G13792G6245G2058TRAIL诱导的细胞凋亡。TRAIL与G2475体G13479G2524,G1039要G17902G17819FAS相关G15519G11345死亡的G13479G7512G3507(FASASSOCIATEDPROTEINWITHDEATHDOMAIN,FADD)G1461G2507G5353G17227的CASPASE8G13435G13864G2465应凋亡G1461G2507G17728导G17902G17347、由BCL2G15519G11345家族G5353G17227的G13459G12902体G713细胞色素C凋亡G1461G2507G17728导G17902G17347以及G17902G17819NFKBG17902G17347G5353G17227的凋亡G1461G2507G17728导G17896G5464诱导细胞发生凋亡1。TRAIL凋亡作用G1039要G2475诱G20587G2475体、G7692因子(NFKB)、细胞FLICEG6245G2058G15519G11345(CFLIP)、凋亡G6245G2058G15519G11345(IAPS)、BCL2G15519G11345家族、SURVIVIN等相关物G17148的调节2。2TRAIL与皮肤疾病皮肤是G1166体最G3835的器官,是机体G2656外G11040之G19400的G3837G9994G4643G19568,由G15932皮、G11507皮G2656皮G991G13464G13467G7512成。G15932皮G1039要由G16294G17148G5430成细胞、黑色素细胞、G7403G7696G8733G7043细胞、G2656G21626G1823G4584细胞等G7512成,G17902G17819G3534G5225G14192G5114与G11507皮相G17842G6521。G11507皮G1039要由纤维、G3534G17148G2656细胞成分等G13464成。近几年来,TRAIL在皮肤增生、凋亡、炎症、免疫等疾病中的研究已成为皮肤药G10714学的研究热点。皮肤是G17819敏G2656炎症的频发部位,发病机G2058复杂,G16294G17148G5430成细胞G2656成纤维细胞等参与了G2465应,TRAIL与G16294G17148G5430成细胞的增生、分化密切相关3,在调节皮肤炎症的发生发展中具有重要的作用,维持了皮肤内环境的稳定。皮肤黑色素瘤黑色素瘤简G12228恶黑,是一G12879G17227源于神经脊黑色素细胞的恶性肿瘤,临床上G4581见,发病率占全身恶性肿瘤的12,G1306近年来有逐渐升高趋G2195,病变部位以皮肤最为多见,其发病G5132较隐匿,G993易G5353G17227患G13785的重视,一般治疗时为时已晚,G1000治疗效果欠佳。故早期诊断、及时治疗特G2047重要。TRAIL作为一种很有潜力的抗癌因子,与其G2475体G13479G2524后,诱导G3835多数肿瘤细3胞的凋亡。黑色素瘤的高发病率与药物治疗的抗药性密切相关,其耐药性与相关的凋亡G2656抗凋亡G3534因G2656G15519G11345的G15932达有关4,GILLESPIES等学G137855研究证实,G15519G11345激酶C的激活能够调节TRAIL诱导的黑色素瘤细胞的凋亡,其机G2058与G15519G11345激酶C能够调节G13459G12902体上游G2656半胱G3837冬酶8G991游的G1461G2507G17728导G17902G17347有关。KURBANOVBM等6用免疫G13464G13467化学方法证实黑色素瘤细胞对TRAIL的敏G5875性与其G15932G19766的DR4G15932达密切相关,G13792WUJJ等7认为TRAIL对黑色素瘤细胞耐G2475与P53G2656P21的G15932达的G991降G2656ERK1/2、AKTG15519G11345的激活密切相关。ZEISEE等8在对TRAIL敏G5875的G1166G12879细胞A375G2656抗TRAIL细胞株IGR37对照研究G15932G7138FLIPG15519G11345的G15932达G2475UVB的调节,在低剂量的UVB照射G991,用TRAIL处G10714的IGR37细胞的凋亡G7138G7186增加,其原因是UVB可以G6245G2058FLIPG6245G2058凋亡G15519G11345的G15932达,G1186G13792促进TRAIL诱导的细胞凋亡。其确切的药物耐G2475性原因有待进一步证实。关于TRAIL诱导变异细胞的凋亡G1461G2507G17728导G17902G17347方G19766尚存在一定的G1117议,LARRIBEREL等9用干细胞因子激活磷脂酰肌醇(G7133)激酶(PI3K)G2656ERK,发现能够强烈的保护黑色素瘤细胞免G2475TRAIL诱导的凋亡,G5430成了SCF/PI3K/AKTG13435G13864瀑G5079凋亡G17902G17347。ZHANGXD等10实验用MEKG6245G2058剂U206G6122MKK1G15519G11345的G7186性负相G15519G11345来G6245G2058ERK1/2G1461G2507,发现能G7186G14891提高对TRAIL敏G5875的色素瘤细胞发生TRAIL诱导的细胞凋亡,这与G13459G12902体的G17340G14192电位的迅速降低G2656SMAC/DIABLO向细胞G17148释放有关。这些G13479果G15932G7138ERK1/2G1461G2507G17902G17347可能阻止黑色素瘤细胞发生TRAIL诱导的凋亡。TRAIL在协同药物治疗黑色素瘤方G19766,许多学G13785也做了G3835量的研究,TRAIL能够与多种抗癌药物发生协同作用,诱导癌细胞的凋亡,提高抗癌药物的疗效11。GILLESPIES等12学G13785实验发现TRAIL能够协同G13464G15519G11345脱乙酰G3534酶G6245G2058剂SBHA杀伤色素瘤细胞,其分子机G2058是在TRAIL存在G991,SBHA能够G991调BCLXL,MCL1ANDXIAPG15519G11345的G15932达,同时上调BH3ONLYPROTEINBIMEL的G15932达。这种诱导肿瘤细胞凋亡G17896G5464可能是G17902G17819细胞的G13459G12902体凋亡G17896G5464实现的。SONGJH等13用21例黑色素瘤细胞株G2656对TRAIL敏G5875的初期黑色素瘤细胞,G9994后检测顺G19094、G1393G6188G8862G14539对TRAIL耐G2475的肿瘤细胞株诱导凋亡作用的协同效应,发现能够增强TRAILG1183导的凋亡作用,其机G2058是G6245G2058细胞内CFLIPG15519G11345的G15932达。VANOVVN等14用G15932皮细胞生G19283因子G6245G2058剂G2656G1134G11787G18252G11428综G2524治疗G1166G12879的EGFRG19463性的黑素瘤细胞,发现能够G7186G14891诱导黑色素瘤细胞的凋亡,其机G2058是G17902G17819G6245G2058PI3KAKTG1461G2507G17728导G17902G17347以及促进TRAILG1183导的细胞凋亡。G2490外IVANOVVN,HEITK15等在实验中证实G1134G11787G18252G19060能够加G5567TRAILG1183导的黑色素瘤细胞的凋亡,其凋亡机G2058为上调细胞G14192G15932G19766的TRAILR1/R2的G15932达G2656G991调CFLIPG15519G11345的G15932达。中药在4治疗黑色素瘤方G19766也G2474G5483了一定的成果,GILLESPIESK等16学G13785实验证实G5052G3835G6131G1120G14832醇能够G2464重诱导TRAILG1183导的黑色素瘤细胞的凋亡。特应性皮炎特应性皮炎AD是G17963G1268易G5875G1022体在环境因素作用G991发生的变G5589G2465应性疾病。多数患G13785以后发生G2754G2924G2656G17819敏性G21775炎,其特G5461G3355为IGEG2656外G2620G15892G2992G18252G12902细胞升高。在G8504G12879皮肤疾病中,TRAIL与其G2475体G13479G2524,激活G19762凋亡G1461G2507G17728导G17896G5464,调节皮肤炎症G2465应,G1186G13792发G6393其作用。VASSINAE等17学G13785发现在特异性皮炎患G13785的外G2620G15892T细胞G2656G2345G7692细胞中与G8503G5132G1166相G8616,TRAIL有G7186G14891G15932达。G1000抗炎作用是因为TRAIL能够诱导G11345G1183素G7131G2475体G6338抗剂(IL1RA)的G15932达。因G11345G1183素G7131与其G2475体G13479G2524后,G1147生强烈的G14280炎效应,G17902G17819IL1RA的G1147生,能阻断G11345G1183素G7131的生物学效应,G1186G13792G1955G17743炎症G2465应。WARNNISSORNP等18学G13785也发现特应性皮炎疾病中有TRAIL的G15932达。这些研究成果可能为治疗特应性皮炎的药物的研发提G1391新的作用靶点。皮肤利什曼原虫病利什曼原虫G6365其G7092G19841G8623体G4504生的脊G7906G2172物G4499G1039的G993同分为G1016G3835G12879,G2375G10240G15904G2172物利什曼原虫及G2766G1095G2172物利什曼原虫。G2081G13785对G1166体G7092G14280病作用,后G13785中有许多G4504生G1166体,其中有的G4504生于皮肤的G5052G3136细胞内,G5353G17227皮肤利什曼病(CUTANEOUSLEISHMANIASIS),G3926G11817G3835利什曼原虫(LMAJOR)G2656G3708G16211G2745利什曼原虫LMEXICANABIAGI,1953GARNHAM,1962在G6117G3281,G7472G8675是G1039要的G14280病虫种。EIDSMOL等19学G13785G18331用凋亡特定的G5506点G19465G6175G8585检测发现在利什曼原虫G3533G1871的上G9177G3824中,TRAIL的MRNAG2656G15519G11345G15932达G7186G14891增加,G1000在皮肤利什曼原虫病患G13785的皮肤G7643本中发现促凋亡G15519G11345TRAILR2的G15932达。这可能是导G14280患G13785G13464G13467G6451G4487G2656G9303G11125的原因。银屑病关节炎银屑病关节炎(PSORIATICARTHRITIS,PSA)是一种与银屑病相关的炎性关节病,具有银屑病皮G11149G5194导G14280关节G2656G2620G3272G17731G13464G13467G11152G11183、肿G13972、G2399G11183、G1737G11840G2656G17828G2172G19568G11873,部分患G13785可有G20618G20630关节炎G2656(G6122)脊G7621炎,病G12255G17813G5322、易复发、晚期可有关节强G11464,导G14280G8543G5235。银屑病患G13785G1343457发生关节炎。G6117G3281PSA患病率G13434为123G259,银屑病是一种T细胞G1183导的G5942性免疫炎症性皮肤病,以G16294G17148G5430成细胞G17819G5242增生G2656G993G4448全分化为特G5461,G11507皮中性G12902细胞G2656激活的G9119G5064细胞G9036G9082G1288G8623细G15892G12661G6209G7366、G11507皮G9195G1998G2656G15892G8981增加的G15892G12661G6925变。TRAIL作为一种G1183导细胞凋亡的一种重要的配体,在银屑病相关的治疗中具有重要的G5859G1053,HOFBAUERLC等20学G13785在一G20045研究中发现,与G8503G5132G1166G13688G15892G9177TRAILG8712G5191相G8616,银屑病关节炎中的TRAILG7186G14891升高。G12520G137855认为,这可能与银屑病中皮肤G17819G5242G15932达TRAIL及其G2475体相关,导G14280G16294G17148G5430成细胞的增生G2656分化异G5132有关,G5194G1000可能激活了NFKBG19762凋亡G1461G2507G17728导G17902G17347,导G14280炎症的发生。3展望TRAIL作为TNF超家族的重要成员,由于能够选择性的杀伤变异细胞G2656病G8614G5875G7591的细胞的凋亡,对G8503G5132细胞G3534本G7092G8614性等G1260点,成为肿瘤研究G20058G3507的热点,近几年来TRAIL在皮肤增生、炎症、免疫等相关疾病的研究中也逐渐成为热G19388,G1306G2052G11458G2081为止,有关皮肤TRAIL的研究G6265G17959G17836G8616较G19658G6967,其在皮肤增生、炎症性疾病中G6210G9448的作用及其机G2058,G1177G19764G11458G2081的研究G17836G993能做G1998确切的G6265G17959。TRAIL在G14270身免疫性疾病中的研究G3281内外研究较G4581,由于在TRAIL的G1461G2507G17728导G17902G17347方G19766研究,有关学G13785G17836存在一定的G1117议,G19668要进一步研究。G1306G19555着对TRAIL及其G1461G2507G17728导G17902G17347研究的G993断深入,其与皮肤免疫、增生、炎症等相关疾病的关系研究也日益G7138确。G18331用RNA沉默、G3534因修饰G6122敲除技术、G15519G11345G17148G13464学等研究,必将对阐G7138TRAIL在皮肤性疾病中地位发G6393重要的作用,为皮肤疾病的治疗提G1391G10714论G3534础,研究TRAIL在皮肤疾病中的研究必将有助于寻找药物作用的新靶点,对提高药物疗效、开发经皮给药G2058剂、防止药物对皮肤的G6451伤具有重要的G5859G1053。A60A61A62A63A64A65A66A67A68A69A68A70A71A72A73A74A75A76A68A77A72A78A71A79A80A81A82A83A84A85A74A86A71A79A87A88A89A68A73A72A90A91A90A78A91A73A71A73A72A79A87A72A89A78A71A92A72A78A71A91A79A91A93A94A95A96A72A90A90A72A97A82A98A88A69A99A100A78A91A96A71A79A68A94A68A78A101A67A83A102A98A88A69A91A90A68A72A79A89A100A78A91A96A71A79A68A79A68A78A101A91A69A96A75A103A104A104A105A75A104A106A107A108A109A110A105A111A102A105A82A64A112A66A99A113A72A101A114A72A102A115A72A69A96A72A69A81A75A97A72A68A115A74A75A84A68A88A95A67A75A68A78A72A114A82A76A91A101A79A69A68A116A88A114A72A78A71A91A79A91A93A97A89A114A102A117A75A95A86A74A118A91A69A74A85A118A73A106A119A74A85A118A72A79A87A73A88A69A92A71A92A71A79A108A77A100A73A71A84A94A85A73A73A68A79A73A71A78A71A120A68A73A69A68A73A71A73A78A72A79A78A70A68A114A72A79A91A70A72A89A68A114A114A73A78A91A85A90A91A117A86A121A83A84A85A74A86A102A71A79A87A88A89A68A87A72A90A91A90A78A91A73A71A73A82A99A68A114A114A76A68A72A78A113A76A71A93A93A68A69A67A83A102A99A68A114A114A87A68A72A78A113A72A79A87A87A71A93A93A68A69A68A79A78A71A72A78A71A91A79A75A117A122A122A107A75A103A103A106A105A108A109A104A103A123A102A117A124A82A64A125A66A67A72A79A73A68A79A97A67A75A92A72A79A84A88A71A73A73A68A79A95A75A99A68A69A79A68A88A73A115A75A68A78A72A114A82A83A88A70A91A69A79A68A89A69A91A73A71A73A93A72A89A78A91A69A69A68A114A72A78A68A87A72A90A91A90A78A91A73A71A73A71A79A87A88A89A71A79A116A114A71A116A72A79A87A78A69A71A116A116A68A69A73A72A90A91A90A78A91A73A71A73A71A79A87A71A92A71A87A71A79A116A77A88A78A79A91A78A71A79A87A71A93A93A68A69A68A79A78A71A72A78A71A79A116A113A88A70A72A79A68A90A71A87A68A69A70A72A114A96A68A69A72A78A71A79A91A89A100A78A68A73A82A67A74A79A92A68A73A78A76A68A69A70A72A78A91A114A67A83A102A83A113A68A67A91A88A69A79A72A114A91A93A71A79A92A68A73A78A71A116A72A78A71A92A68A87A68A69A70A72A78A91A114A91A116A100A75A117A122A122A124A75A103A117A103A106A110A108A109A103A107A124A124A102A104A82A64A126A66A115A72A78A100A72A70A91A91A69A78A113A100A80A75A97A91A116A68A79A69A71A68A87A68A69A83A75A127A68A69A114A100A79A81A82A94A91A114A91A79A116A68A69A72A70A91A114A68A89A88A114A72A69A77A114A72A89A96A77A91A128A102A102A79A68A101A89A114A88A68A73A78A91A72A90A91A90A78A91A73A71A73A72A79A87A87A69A88A116A69A68A73A71A73A78A72A79A89A68A71A79A70A68A114A72A79A91A70A72A82A83A69A68A79A87A73A81A91A114A81A68A87A67A83A102A83A69A68A79A87A73A71A79A70A91A114A68A89A88A114A72A69A70A68A87A71A89A71A79A68A75A117A122A122A103A75A111A106A123A108A109A103A104A103A102A107A82A64A129A66A130A71A114A114A68A73A90A71A68A115A75A131A113A72A79A116A119A76A75A127A68A69A73A68A100A118A82A132A72A69A71A72A77A114A68A68A128A90A69A68A73A73A71A91A79A91A93A90A69A91A78A68A71A79A96A71A79A72A73A68A99A68A90A73A71A114A91A79A71A79A113A88A70A72A79A70A68A114A72A79A91A70A72A89A68A114A114A73A69A68A116A88A114A72A78A68A73A73A68A79A73A71A78A71A92A71A78A100A78A91A83A84A85A74A86A102A71A79A87A88A89A68A87A72A90A91A90A78A91A73A71A73A82A81A91A114A99A72A79A89A68A69A83A113A68A69A67A83A102A81A91A114A68A89A88A114A72A69A89A72A79A89A68A69A78A113A68A69A72A90A68A88A78A71A89A73A75A117A122A122A123A75A107A106A107A108A109A110A110A105A102A111A110A82A64A133A66A80A88A69A77A72A79A91A92A97A81A75A130A68A71A114A68A79A99A99A75A95A68A89A96A68A69A86A95A75A68A78A72A114A82A98A93A93A71A89A71A68A79A78A83A84A85A74A86A102A84A103A121A76A84A107A102A70A68A87A71A72A78A68A87A72A90A91A90A78A91A73A71A73A71A79A70A68A114A72A79A91A70A72A89A68A114A114A73A77A100A78A88A70A91A69A79A68A89A69A91A73A71A73A93A72A89A78A91A69A102A69A68A114A72A78A68A87A72A90A91A90A78A91A73A71A73A102A71A79A87A88A89A71A79A116A114A71A116A72A79A87A106A83A84A85A74A86A108A82A67A74A79A92A68A73A78A76A68A69A70A72A78A91A114A67A83A102A83A113A68A67A91A88A69A79A72A114A91A93A71A79A92A68A73A78A71A116A72A78A71A92A68A87A68A69A70A72A78A91A114A91A116A100A75A117A122A122A123A75A103A117A123A106A123A108A109A103A122A103A122A102A104A826A64A134A66A135A88A67A67A75A131A113A72A79A116A119A76A75A130A71A114A114A68A73A90A71A68A115A75A68A78A72A114A82A115A68A114A68A89A78A71A91A79A93A91A69A83A84A85A74A86A69A68A73A71A73A78A72A79A89A68A69A68A73A88A114A78A73A71A79A70A68A114A72A79A91A70A72A89A68A114A114A73A101A71A78A113A113A71A116A113A90A69A91A114A71A93A68A69A72A78A71A92A68A90A91A78A68A79A78A71A72A114A82A95A98A97A115A86A68A78A78A67A83A102A95A98A97A115A114A68A78A78A68A69A73A75A117A122A122A123A75A123A111A104A106A104A108A109A103A104A107A122A102A107A82A64A136A66A131A68A71A73A68A98A75A135A68A71A89A113A68A79A78A113A72A114A81A75A115A89A113A101A72A69A120A83A75A68A78A72A114A82A84A68A73A71A73A78A72A79A89A68A91A93A113A88A70A72A79A70A68A114A72A79A91A70A72A89A68A114A114A73A72A116A72A71A79A73A78A78A113A68A87A68A72A78A113A114A71A116A72A79A87A83A84A85A74A86A71A73A69A68A92A68A69A73A68A87A77A100A88A114A78A69A72A92A71A91A114A68A78A102A97A69A72A87A71A72A78A71A91A79A92A71A72A87A91A101A79A69A68A116A88A114A72A78A71A91A79A91A93A95A86A74A118A82A67A74A79A92A68A73A78A76A68A69A70A72A78A91A114A67A83A102A83A113A68A67A91A88A69A79A72A114A91A93A71A79A92A68A73A78A71A116A72A78A71A92A68A87A68A69A70A72A78A91A114A91A116A100A75A117A122A122A107A75A103A117A124A106A107A108A109A111A107A110A102A123A107A82A64A137A66A86A72A69A69A71A77A68A69A68A86A75A80A113A72A114A68A87A81A75A83A72A69A78A72A69A68A102A76A68A89A96A68A69A78A115A75A68A78A72A114A82A118A74A124A80A70A68A87A71A72A78A68A73A90A69A91A78A68A89A78A71A91A79A72A116A72A71A79A73A78A83A84A85A74A86A102A71A79A87A88A89A68A87A72A90A91A90A78A91A73A71A73A71A79A90A69A71A70A72A69A100A113A88A70A72A79A70A68A114A72A79A91A89A100A78A68A73A82A99A68A114A114A76A68A72A78A113A76A71A93A93A68A69A67A83A102A99A68A114A114A87A68A72A78A113A72A79A87A87A71A93A93A68A69A68A79A78A71A72A78A71A91A79A75A117A122A122A107A75A103A103A106A103A122A108A109A103A122A105A107A102A104A103A82A64A65A138A66A131A113A72A79A116A119A76A75A97A91A69A69A91A101A67A81A75A131A113A72A79A116A119A139A75A68A78A72A114A82A85A89A78A71A92A72A78A71A91A79A91A93A98A84A80A103A121A117A90A69A91A78A68A89A78A73A70A68A114A72A79A91A70A72A89A68A114A114A73A93A69A91A70A83A84A85A74A86A102A71A79A87A88A89A68A87A72A90A91A90A78A91A73A71A73A77A100A71A79A113A71A77A71A78A71A79A116A115A70A72A89A121A76A74A85A97A86A140A69A68A114A68A72A73A68A93A69A91A70A70A71A78A91A89A113A91A79A87A69A71A72A82A140A79A89A91A116A68A79A68A67A83A102A140A79A89A91A116A68A79A68A75A117A122A122A124A75A117A117A106A103A104A108A109A117A105A110A104A102A105A103A82A64A65A65A66A97A91A79A72A92A71A87A72A97A75A94A116A99A118A75A67A72A120A71A69A68A113A71A85A75A68A78A72A114A82A115A68A114A68A89A78A71A92A71A78A100A91A93A83A84A85A74A86A102A70A68A87A71A72A78A68A87A72A90A91A90A78A91A73A71A73A91A93A89A72A79A89A68A69A89A68A114A114A73A72A79A87A73A100A79A68A69A116A100A101A71A78A113A87A69A88A116A73A109A78A113A68A78A69A72A71A114A78A91A79A91A79A102A78A91A128A71A89A89A72A79A89A68A69A78A113A68A69A72A90A68A88A78A71A89A73A106A69A68A92A71A68A101A108A82A74A79A78A67A140A79A89A91A114A67A83A102A74A79A78A68A69A79A72A78A71A91A79A72A114A141A91A88A69A79A72A114A91A93A91A79A89A91A114A91A116A100A75A103A104A104A104A75A103A123A106A107A108A109A111A104A124A102A105A122A117A82A64A65A112A66A130A71A114A114A68A73A90A71A68A115A75A97A91A69A69A91A101A67A75A131A113A72A79A116A119A76A75A68A78A72A114A82A97A71A70A90A114A72A100A73A72A89A69A88A89A71A72A114A69A91A114A68A71A79A73A100A79A68A69A116A71A73A78A71A89A71A79A87A88A89A78A71A91A79A91A93A72A90A91A90A78A91A73A71A73A77A100A78A113A68A113A71A73A78A91A79A68A87A68A72A89A68A78A100A114A72A73A68A71A79A113A71A77A71A78A91A69A115A97A127A85A72A79A87A83A84A85A74A86A71A79A70A68A114A72A79A91A70A72A89A68A114A114A73A82A85A90A91A90A78A91A73A71A73A67A83A102A85A90A91A90A78A91A73A71A73A109A72A79A71A79A78A68A69A79A72A78A71A91A79A72A114A141A91A88A69A79A72A114A91A79A90A69A91A116A69A72A70A70A68A87A89A68A114A114A87A68A72A78A113A75A117A122A122A110A75A103A103A106A103A117A108A109A117A117A123A103A102A110A123A82A64A65A125A66A115A91A79A116A67A127A75A115A91A79A116A76A80A75A127A68A69A114A100A79A81A75A68A78A72A114A82A99A71A73A90A114A72A78A71A79A87A91A101A79A102A69A68A116A88A114A72A78A71A91A79A91A93A89A68A114A114A88A114A72A69A95A72A73A102A72A73A73A91A89A71A72A78A68A87A87A68A72A78A113A87A91A70A72A71A79A102A114A71A96A68A71A79A78A68A69A114A68A88A96A71A79A102A103A77A68A78A72A102A89A91A79A92A68A69A78A71A79A116A68A79A120A100A70A68A102A114A71A96A68A71A79A113A71A77A71A78A91A69A100A90A69A91A78A68A71A79A73A78A91A69A68A73A78A91A69A68A78A88A70A91A69A79A68A89A69A91A73A71A73A93A72A89A78A91A69A102A69A68A114A72A78A68A87A72A90A91A90A78A91A73A71A73A102A71A79A87A88A89A71A79A116A114A71A116A72A79A87A102A71A79A87A88A89A68A87A72A90A91A90A78A91A73A71A73A71A79A113A88A70A72A79A70A68A114A72A79A91A70A72A89A68A114A114A73A82A99A114A71A79A99A72A79A89A68A69A84A68A73A67A83A102A99A114A71A79A71A89A72A114A89A72A79A89A68A69A69A68A73A68A72A69A89A113A109A72A79A91A93A93A71A89A71A72A114A141A91A88A69A79A72A114A91A93A78A113A68A85A70A68A69A71A89A72A79A85A73A73A91A89A71A72A78A71A91A79A93A91A69A99A72A79A89A68A69A84A68A73A68A72A69A89A113A75A117A122A122A124A75A104A106A103A103A108A109A107A117A123A123A102A110A110A82A64A65A126A66A74A92A72A79A91A92A132A94A75A127A68A71A83A80A82A99A91A70A77A71A79A68A87A78A69A68A72A78A70A68A79A78A101A71A78A113A98A130A95A84A71A79A113A71A77A71A78A91A69A73A72A79A87A72A69A73A68A79A71A

温馨提示

  • 1. 本站所有资源如无特殊说明,都需要本地电脑安装OFFICE2007和PDF阅读器。图纸软件为CAD,CAXA,PROE,UG,SolidWorks等.压缩文件请下载最新的WinRAR软件解压。
  • 2. 本站的文档不包含任何第三方提供的附件图纸等,如果需要附件,请联系上传者。文件的所有权益归上传用户所有。
  • 3. 本站RAR压缩包中若带图纸,网页内容里面会有图纸预览,若没有图纸预览就没有图纸。
  • 4. 未经权益所有人同意不得将文件中的内容挪作商业或盈利用途。
  • 5. 人人文库网仅提供信息存储空间,仅对用户上传内容的表现方式做保护处理,对用户上传分享的文档内容本身不做任何修改或编辑,并不能对任何下载内容负责。
  • 6. 下载文件中如有侵权或不适当内容,请与我们联系,我们立即纠正。
  • 7. 本站不保证下载资源的准确性、安全性和完整性, 同时也不承担用户因使用这些下载资源对自己和他人造成任何形式的伤害或损失。

评论

0/150

提交评论